This report was recently updated on December 19 2024 with the latest and most recent
market numbers
Global Digital Therapeutics Market Size, Trends & Analysis - Forecasts to 2029 By Offering (Programs, Software/Platforms, and Virtual Reality/Games), By Revenue Model (Subscription, One time Purchase/Licensing, and Outcome/Value based), By Sales Channel (B2C (Patients and Caregivers), B2B (Providers, Payers, and Employers), Pharmaceutical Companies, and Others), By Application (Preventive Applications (Prediabetes, Obesity, Nutrition, Lifestyle Management, and Other Preventive Applications) and Treatment/Care-related Applications (Diabetes, CNS Disorders, Mental Health Disorders, Chronic Respiratory Disorders, Musculoskeletal Disorders, Cardiovascular Diseases, Smoking Cessation, Medication Adherence, Gastrointestinal Disorders, Substance Use & Addiction Management, Rehabilitation & Patient Care, and Other Treatment/Care-related Applications)), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global digital therapeutics market is analysed to grow from USD 6.2 billion in 2023 to USD 22.3 billion in 2029, and is anticipated to grow at compound annual growth rate (CAGR) of 28.4% during the forecast period of 2024 to 2029. Digital therapeutics often utilize technologies such as mobile apps, wearable devices, and software programs to deliver personalized treatments and interventions. These interventions are distinct from general health and wellness apps by their focus on providing clinically proven outcomes.
The main driving factors propelling the market growth are the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders and the rising need for cost containment. As these diseases become more widespread, there is a growing urgency to find effective, scalable solutions for treatment and management. Additionally, there is a pressing need for cost containment in healthcare. Digital therapeutics offer a promising avenue for addressing both challenges simultaneously. By providing accessible, technology-driven interventions, they can help manage chronic conditions more efficiently and cost-effectively. This dual benefit of improving patient outcomes while reducing healthcare expenditures drives the rapid growth of the digital therapeutics market. One significant opportunity in the digital therapeutics market lies in its potential to enhance patient engagement and adherence to treatment regimens. Digital therapeutics platforms can offer personalized experiences, interactive interfaces, and real-time feedback, making them more engaging and motivating for patients.
A major market restraint is the challenge of regulatory compliance and approval processes. Unlike traditional pharmaceuticals, digital therapeutics often require novel regulatory pathways for approval, which can be complex and time-consuming.
Based on offering, the market is segmented into programs, software/platforms, and virtual reality/games. The software/platforms segment is expected to hold the largest share of the market during the forecast period. The growth is attributed to the rising dependence on advanced software solutions to administer therapeutic treatments, signifying an expanding preference for digital health alternatives. The prominence of this segment underscores the pivotal role of cutting-edge technologies and platforms in influencing the growth of the worldwide market.
The virtual reality/games segment is projected to grow fastest during the forecast period. Virtual reality (VR) therapy and gamified interventions offer interactive experiences that enhance patient motivation and adherence to treatment regimens. This segment capitalizes on the appeal of gaming technology to deliver effective therapeutic interventions, driving its rapid growth in the market. For instance, the U.S. Food and Drug Administration (FDA) approved Akili, Inc.'s video game therapy EndeavorRx in 2020 for use in treating children with attention-deficit/hyperactivity disorder (ADHD).
Based on revenue model, the market is segmented into subscription, one time purchase/licensing, and outcome/value based. The subscription segment is expected to hold the largest share of the market during the forecast period. The subscription model prevails in the digital therapeutics market, with users paying recurring fees for continued access to therapeutic services or content. This model offers a steady stream of revenue for providers and ensures ongoing engagement with users. It provides a predictable income stream while offering users consistent access to treatment and support over time.
The outcome/value based segment is projected to grow fastest during the forecast period. In this model, payment is based on the achievement of predefined outcomes or the demonstrated value of the digital therapeutics intervention in improving patient health outcomes. This model is gaining traction as it aligns incentives between providers, payers, and patients and ensures that payment is tied to the actual effectiveness of the intervention.
Based on sales channel, the market is segmented into B2C, B2B, pharmaceutical companies, and others. The B2B segment is expected to hold the largest share of the market during the forecast period due to the growing acceptance by payers, employers, and healthcare providers who recognize the advantages of digital therapeutics. Moreover, the pharmaceutical industry's inclination to integrate digital therapeutics with their medications is expected to further stimulate the adoption of digital therapeutics among these end user groups.
The pharmaceutical companies segment is projected to grow fastest during the forecast period. Pharmaceutical firms increasingly recognize the value of integrating digital therapeutics with their drug products to enhance treatment outcomes and patient adherence. This collaboration allows pharmaceutical companies to offer comprehensive healthcare solutions, tapping into a broader market and meeting the growing demand for integrated approaches to healthcare delivery.
Based on application, the market is segmented into preventive applications, and treatment/care-related applications. The treatment/care-related applications segment is expected to hold the largest share of the market during the forecast period. The growth of the treatment-focused applications segment is attributed to the increasing financial strain associated with treating these conditions, as well as investments in digital therapeutics aimed at fostering the development of affordable and adaptable treatment platforms for such ailments.
The preventive applications segment is projected to grow fastest during the forecast period. With a focus on preventing diseases before they occur, these applications offer personalized interventions, lifestyle modification programs, and health monitoring tools. As individuals prioritize preventive healthcare to maintain overall well-being, the demand for digital therapeutics aimed at preventing diseases and promoting healthy habits is expected to surge during the forecast period.
North America is analyzed to be the largest region in the global digital therapeutics market during the forecast period. North America's robust technological infrastructure, characterized by widespread smartphone and internet usage, fosters the adoption of digital healthcare platforms and applications. Patients in the region are progressively turning to connected devices like smartphones to engage with digital treatments for managing conditions, monitoring progress, and communicating with healthcare professionals.
Asia Pacific is analyzed to be the fastest-growing region in the digital therapeutics market during the forecast period. The prevalence of chronic diseases such as diabetes, cardiovascular conditions, and respiratory disorders is increasing in the region, driving demand for effective digital therapeutics solutions. With rising incomes and growing healthcare awareness, consumers in Asia Pacific are increasingly willing to invest in digital health solutions, including digital therapeutics, to manage their health effectively. Asia Pacific is witnessing significant growth in healthcare infrastructure, including hospitals, clinics, and digital health platforms, facilitating the adoption of digital therapeutics. Rising internet penetration rates in Asia Pacific enable widespread access to digital therapeutics platforms, allowing patients to engage with treatment remotely.
Noom, Inc, Teladoc Health, Inc., Omada Health, Inc., WellDoc, Inc, Biofourmis, Better Therapeutics, Inc, Amalgm Rx, CogniFit Inc, Headspace Health, Propeller Health, Virta Health Corp, 2Morrow, Inc., Realizedcare, Canary Health, Twill Inc., Click Therapeutics, Inc., Akili, Inc., Cognoa, Inc, Wellthy Therapeutics Pvt. Ltd., and Kaia Health, among others, are some of the key players operating in the global market.
Please note: This is not an exhaustive list of companies profiled in the report.
In July 2023, Teladoc Health announced expanding its collaboration with Microsoft to integrate Microsoft Azure OpenAI Service, Azure Cognitive Services, and the Nuance Dragon Ambient eXperience (DAX) into the Teladoc Health Solo platform.
In March 2022, Propeller Health announced integrations with multiple leading Electronic Health Record (EHR) systems, introduced a new solution to enable remote therapeutic monitoring (RTM) by healthcare providers, and launched digital platform updates to enable respiratory care at home, in-clinic, and on-the-go.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL DIGITAL THERAPEUTICS MARKET, BY OFFERING
4.1 Introduction
4.2 Digital Therapeutics Market: Offering Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Programs
4.4.1 Programs Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Software/Platforms
4.5.1 Software/Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Virtual Reality/Games
4.6.1 Virtual Reality/Games Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL
5.1 Introduction
5.2 Digital Therapeutics Market: Revenue Model Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Subscription
5.4.1 Subscription Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 One time Purchase/Licensing
5.5.1 One time Purchase/Licensing Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Outcome/Value based
5.6.1 Outcome/Value based Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL
6.1 Introduction
6.2 Digital Therapeutics Market: Sales Channel Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 B2C
6.4.1 B2C Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1.1 Patients
6.4.1.2 Caregivers
6.5 B2B
6.5.1 B2B Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1.1 Providers
6.5.1.2 Payers
6.5.1.3 Employers
6.6 Pharmaceutical Companies
6.6.1 Pharmaceutical Companies Market Estimates and Forecast, 2021-2029 (USD Million)
6.7 Others
6.7.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
7 GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION
7.1 Introduction
7.2 Digital Therapeutics Market: Application Scope Key Takeaways
7.3 Revenue Growth Analysis, 2023 & 2029
7.4 Preventive Applications
7.4.1 Preventive Applications Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.1.1 Prediabetes
7.4.1.2 Obesity
7.4.1.3 Nutrition
7.4.1.4 Lifestyle Management
7.4.1.5 Other Preventive Applications
7.5 Treatment/Care-related Applications
7.5.1 Treatment/Care-related Applications Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.1.1 Diabetes
7.5.1.2 CNS Disorders
7.5.1.3 Mental Health Disorders
7.5.1.4 Chronic Respiratory Disorders
7.5.1.5 Musculoskeletal Disorders
7.5.1.6 Cardiovascular Diseases
7.5.1.7 Smoking Cessation
7.5.1.8 Medication Adherence
7.5.1.9 Gastrointestinal Disorders
7.5.1.10 Substance Use & Addiction Management
7.5.1.11 Rehabilitation & Patient Care
7.5.1.12 Other Treatment/Care-related Applications
8 GLOBAL DIGITAL THERAPEUTICS MARKET, BY REGION
8.1 Introduction
8.2 North America Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.2.1 By Offering
8.2.2 By Revenue Model
8.2.3 By Sales Channel
8.2.4 By Application
8.2.5 By Country
8.2.5.1 U.S. Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.2.5.1.1 By Offering
8.2.5.1.2 By Revenue Model
8.2.5.1.3 By Sales Channel
8.2.5.1.4 By Application
8.2.5.2 Canada Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.2.5.2.1 By Offering
8.2.5.2.2 By Revenue Model
8.2.5.2.3 By Sales Channel
8.2.5.2.4 By Application
8.2.5.3 Mexico Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.2.5.3.1 By Offering
8.2.5.3.2 By Revenue Model
8.2.5.3.3 By Sales Channel
8.2.5.3.4 By Application
8.3 Europe Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.1 By Offering
8.3.2 By Revenue Model
8.3.3 By Sales Channel
8.3.4 By Application
8.3.5 By Country
8.3.5.1 Germany Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.1.1 By Offering
8.3.5.1.2 By Revenue Model
8.3.5.1.3 By Sales Channel
8.3.5.1.4 By Application
8.3.5.2 U.K. Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.2.1 By Offering
8.3.5.2.2 By Revenue Model
8.3.5.2.3 By Sales Channel
8.3.5.2.4 By Application
8.3.5.3 France Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.3.1 By Offering
8.3.5.3.2 By Revenue Model
8.3.5.3.3 By Sales Channel
8.3.5.3.4 By Application
8.3.5.4 Italy Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.4.1 By Offering
8.3.5.4.2 By Revenue Model
8.3.5.4.3 By Sales Channel
8.3.5.4.4 By Application
8.3.5.5 Spain Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.5.1 By Offering
8.3.5.5.2 By Revenue Model
8.3.5.5.3 By Sales Channel
8.3.5.5.4 By Application
8.3.5.6 Netherlands Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.6.1 By Offering
8.3.5.6.2 By Revenue Model
8.3.5.6.3 By Sales Channel
8.3.5.6.4 By Application
8.3.5.7 Rest of Europe Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.7.1 By Offering
8.3.5.7.2 By Revenue Model
8.3.5.7.3 By Sales Channel
8.3.5.7.4 By Application
8.4 Asia Pacific Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.1 By Offering
8.4.2 By Revenue Model
8.4.3 By Sales Channel
8.4.4 By Application
8.4.5 By Country
8.4.5.1 China Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.1.1 By Offering
8.4.5.1.2 By Revenue Model
8.4.5.1.3 By Sales Channel
8.4.5.1.4 By Application
8.4.5.2 Japan Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.2.1 By Offering
8.4.5.2.2 By Revenue Model
8.4.5.2.3 By Sales Channel
8.4.5.2.4 By Application
8.4.5.3 India Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.3.1 By Offering
8.4.5.3.2 By Revenue Model
8.4.5.3.3 By Sales Channel
8.4.5.3.4 By Application
8.4.5.4 South Korea Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.4.1 By Offering
8.4.5.4.2 By Revenue Model
8.4.5.4.3 By Sales Channel
8.4.5.4.4 By Application
8.4.5.5 Singapore Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.5.1 By Offering
8.4.5.5.2 By Revenue Model
8.4.5.5.3 By Sales Channel
8.4.5.5.4 By Application
8.4.5.6 Malaysia Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.6.1 By Offering
8.4.5.6.2 By Revenue Model
8.4.5.6.3 By Sales Channel
8.4.5.6.4 By Application
8.4.5.7 Thailand Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.7.1 By Offering
8.4.5.7.2 By Revenue Model
8.4.5.7.3 By Sales Channel
8.4.5.7.4 By Application
8.4.5.8 Indonesia Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.8.1 By Offering
8.4.5.8.2 By Revenue Model
8.4.5.8.3 By Sales Channel
8.4.5.8.4 By Application
8.4.5.9 Vietnam Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.9.1 By Offering
8.4.5.9.2 By Revenue Model
8.4.5.9.3 By Sales Channel
8.4.5.9.4 By Application
8.4.5.10 Taiwan Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.10.1 By Offering
8.4.5.10.2 By Revenue Model
8.4.5.10.3 By Sales Channel
8.4.5.10.4 By Application
8.4.5.11 Rest of Asia Pacific Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.11.1 By Offering
8.4.5.11.2 By Revenue Model
8.4.5.11.3 By Sales Channel
8.4.5.11.4 By Application
8.5 Middle East and Africa Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.1 By Offering
8.5.2 By Revenue Model
8.5.3 By Sales Channel
8.5.4 By Application
8.5.5 By Country
8.5.5.1 Saudi Arabia Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.5.1.1 By Offering
8.5.5.1.2 By Revenue Model
8.5.5.1.3 By Sales Channel
8.5.5.1.4 By Application
8.5.5.2 U.A.E. Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.5.2.1 By Offering
8.5.5.2.2 By Revenue Model
8.5.5.2.3 By Sales Channel
8.5.5.2.4 By Application
8.5.5.3 Israel Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.4.3.1 By Offering
8.5.4.3.2 By Revenue Model
8.5.4.3.3 By Sales Channel
8.5.5.3.4 By Application
8.5.5.4 South Africa Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.5.4.1 By Offering
8.5.5.4.2 By Revenue Model
8.5.5.4.3 By Sales Channel
8.5.5.4.4 By Application
8.5.5.5 Rest of Middle East and Africa Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.5.5.1 By Offering
8.5.5.5.2 By Revenue Model
8.5.5.5.2 By Sales Channel
8.5.5.5.4 By Application
8.6 Central & South America Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.6.1 By Offering
8.6.2 By Revenue Model
8.6.3 By Sales Channel
8.6.4 By Application
8.6.5 By Country
8.6.5.1 Brazil Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.6.5.1.1 By Offering
8.6.5.1.2 By Revenue Model
8.6.5.1.3 By Sales Channel
8.6.5.1.4 By Application
8.6.5.2 Argentina Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.6.5.2.1 By Offering
8.6.5.2.2 By Revenue Model
8.6.5.2.3 By Sales Channel
8.6.5.2.4 By Application
8.6.5.3 Chile Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.6.5.3.1 By Offering
8.6.5.3.2 By Revenue Model
8.6.5.3.3 By Sales Channel
8.6.5.5.4 By Application
8.6.5.4 Rest of Central & South America Digital Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
8.6.5.4.1 By Offering
8.6.5.4.2 By Revenue Model
8.6.5.4.3 By Sales Channel
8.6.5.4.4 By Application
9 COMPETITIVE LANDCAPE
9.1 Company Market Share Analysis
9.2 Four Quadrant Positioning Matrix
9.2.1 Market Leaders
9.2.2 Market Visionaries
9.2.3 Market Challengers
9.2.4 Niche Market Players
9.3 Vendor Landscape
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Rest of the World
9.4 Company Profiles
9.4.1 Noom, Inc
9.4.1.1 Business Description & Financial Analysis
9.4.1.2 SWOT Analysis
9.4.1.3 Products & Services Offered
9.4.1.4 Strategic Alliances between Business Partners
9.4.2 TELADOC HEALTH, INC.
9.4.2.1 Business Description & Financial Analysis
9.4.2.2 SWOT Analysis
9.4.2.3 Products & Services Offered
9.4.2.4 Strategic Alliances between Business Partners
9.4.3 Omada Health, Inc.
9.4.3.1 Business Description & Financial Analysis
9.4.3.2 SWOT Analysis
9.4.3.3 Products & Services Offered
9.4.3.4 Strategic Alliances between Business Partners
9.4.4 WellDoc, Inc
9.4.4.1 Business Description & Financial Analysis
9.4.4.2 SWOT Analysis
9.4.4.3 Products & Services Offered
9.4.4.4 Strategic Alliances between Business Partners
9.4.5 Biofourmis
9.4.5.1 Business Description & Financial Analysis
9.4.5.2 SWOT Analysis
9.4.5.3 Products & Services Offered
9.4.5.4 Strategic Alliances between Business Partners
9.4.6 BETTER THERAPEUTICS, INC
9.4.6.1 Business Description & Financial Analysis
9.4.6.2 SWOT Analysis
9.4.6.3 Products & Services Offered
9.4.6.4 Strategic Alliances between Business Partners
9.4.7 Amalgm Rx
9.4.7.1 Business Description & Financial Analysis
9.4.7.2 SWOT Analysis
9.4.7.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.8 CogniFit Inc
9.4.8.1 Business Description & Financial Analysis
9.4.8.2 SWOT Analysis
9.4.8.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.9 HEADSPACE HEALTH
9.4.9.1 Business Description & Financial Analysis
9.4.9.2 SWOT Analysis
9.4.9.3 Products & Services Offered
9.4.9.4 Strategic Alliances between Business Partners
9.4.10 Propeller Health
9.4.10.1 Business Description & Financial Analysis
9.4.10.2 SWOT Analysis
9.4.10.3 Products & Services Offered
9.4.10.4 Strategic Alliances between Business Partners
9.4.11 VIRTA HEALTH CORP
9.4.11.1 Business Description & Financial Analysis
9.4.11.2 SWOT Analysis
9.4.11.3 Products & Services Offered
9.4.11.4 Strategic Alliances between Business Partners
9.4.12 2Morrow, Inc.
9.4.12.1 Business Description & Financial Analysis
9.4.12.2 SWOT Analysis
9.4.12.3 Products & Services Offered
9.4.12.4 Strategic Alliances between Business Partners
9.4.13 Realizedcare
9.4.13.1 Business Description & Financial Analysis
9.4.13.2 SWOT Analysis
9.4.13.3 Products & Services Offered
9.4.13.4 Strategic Alliances between Business Partners
9.4.14 Canary Health
9.4.14.1 Business Description & Financial Analysis
9.4.14.2 SWOT Analysis
9.4.14.3 Products & Services Offered
9.4.14.4 Strategic Alliances between Business Partners
9.4.15 Twill Inc.
9.4.15.1 Business Description & Financial Analysis
9.4.15.2 SWOT Analysis
9.4.15.3 Products & Services Offered
9.4.15.4 Strategic Alliances between Business Partners
9.4.16 Click Therapeutics, Inc.
9.4.16.1 Business Description & Financial Analysis
9.4.16.2 SWOT Analysis
9.4.16.3 Products & Services Offered
9.4.16.4 Strategic Alliances between Business Partners
9.4.17 AKILI, INC.
9.4.17.1 Business Description & Financial Analysis
9.4.17.2 SWOT Analysis
9.4.17.3 Products & Services Offered
9.4.17.4 Strategic Alliances between Business Partners
9.4.18 HCLTech
9.4.18.1 Business Description & Financial Analysis
9.4.18.2 SWOT Analysis
9.4.18.3 Products & Services Offered
9.4.18.4 Strategic Alliances between Business Partners
9.4.19 Wellthy Therapeutics Pvt. Ltd.
9.4.19.1 Business Description & Financial Analysis
9.4.19.2 SWOT Analysis
9.4.19.3 Products & Services Offered
9.4.19.4 Strategic Alliances between Business Partners
9.4.20 Kaia Health
9.4.20.1 Business Description & Financial Analysis
9.4.20.2 SWOT Analysis
9.4.20.3 Products & Services Offered
9.4.20.4 Strategic Alliances between Business Partners
9.4.21 Other Companies
9.4.21.1 Business Description & Financial Analysis
9.4.21.2 SWOT Analysis
9.4.21.3 Products & Services Offered
9.4.21.4 Strategic Alliances between Business Partners
10 RESEARCH METHODOLOGY
10.1 Market Introduction
10.1.1 Market Definition
10.1.2 Market Scope & Segmentation
10.2 Information Procurement
10.2.1 Secondary Research
10.2.1.1 Purchased Databases
10.2.1.2 GMEs Internal Data Repository
10.2.1.3 Secondary Resources & Third Party Perspectives
10.2.1.4 Company Information Sources
10.2.2 Primary Research
10.2.2.1 Various Types of Respondents for Primary Interviews
10.2.2.2 Number of Interviews Conducted throughout the Research Process
10.2.2.3 Primary Stakeholders
10.2.2.4 Discussion Guide for Primary Participants
10.2.3 Expert Panels
10.2.3.1 Expert Panels Across 30+ Industry
10.2.4 Paid Local Experts
10.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
10.3 Market Estimation
10.3.1 Top-Down Approach
10.3.1.1 Macro-Economic Indicators Considered
10.3.1.2 Micro-Economic Indicators Considered
10.3.2 Bottom Up Approach
10.3.2.1 Company Share Analysis Approach
10.3.2.2 Estimation of Potential Product Sales
10.4 Data Triangulation
10.4.1 Data Collection
10.4.2 Time Series, Cross Sectional & Panel Data Analysis
10.4.3 Cluster Analysis
10.5 Analysis and Output
10.5.1 Inhouse AI Based Real Time Analytics Tool
10.5.2 Output From Desk & Primary Research
10.6 Research Assumptions & Limitations
10.7.1 Research Assumptions
10.7.2 Research Limitations
LIST OF TABLES
1 Global Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
2 Programs Market, By Region, 2021-2029 (USD Million)
3 Software/Platforms Market, By Region, 2021-2029 (USD Million)
4 Virtual Reality/Games Market, By Region, 2021-2029 (USD Million)
5 Global Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
6 Subscription Market, By Region, 2021-2029 (USD Million)
7 One time Purchase/Licensing Market, By Region, 2021-2029 (USD Million)
8 Outcome/Value based Market, By Region, 2021-2029 (USD Million)
9 Global Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
10 B2C Market, By Region, 2021-2029 (USD Million)
11 Patients Market, By Region, 2021-2029 (USD Million)
12 Caregivers Market, By Region, 2021-2029 (USD Million)
13 B2B Market, By Region, 2021-2029 (USD Million)
14 Providers Market, By Region, 2021-2029 (USD Million)
15 Payers Market, By Region, 2021-2029 (USD Million)
16 Employers Market, By Region, 2021-2029 (USD Million)
17 Pharmaceutical Companies Market, By Region, 2021-2029 (USD Million)
18 Others Market, By Region, 2021-2029 (USD Million)
19 Global Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
20 Preventive Applications Market, By Region, 2021-2029 (USD Million)
21 Prediabetes Market, By Region, 2021-2029 (USD Million)
22 Obesity Market, By Region, 2021-2029 (USD Million)
23 Nutrition Market, By Region, 2021-2029 (USD Million)
24 Lifestyle Management Market, By Region, 2021-2029 (USD Million)
25 Other Preventive Applications Market, By Region, 2021-2029 (USD Million)
26 TREATMENT/CARE-RELATED APPLICATIONS Market, By Region, 2021-2029 (USD Million)
27 Diabetes Market, By Region, 2021-2029 (USD Million)
28 CNS Disorders Market, By Region, 2021-2029 (USD Million)
29 Mental Health Disorders Market, By Region, 2021-2029 (USD Million)
30 Chronic Respiratory Disorders Market, By Region, 2021-2029 (USD Million)
31 Musculoskeletal Disorders Market, By Region, 2021-2029 (USD Million)
32 Cardiovascular Diseases Market, By Region, 2021-2029 (USD Million)
33 Smoking Cessation Market, By Region, 2021-2029 (USD Million)
34 Medication Adherence Market, By Region, 2021-2029 (USD Million)
35 Gastrointestinal Disorders Market, By Region, 2021-2029 (USD Million)
36 Substance Use & Addiction Management Market, By Region, 2021-2029 (USD Million)
37 Rehabilitation & Patient Care Market, By Region, 2021-2029 (USD Million)
38 Other Treatment/Care-related Applications Market, By Region, 2021-2029 (USD Million)
39 Regional Analysis, 2021-2029 (USD Million)
40 North America Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
41 North America Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
42 North America Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
43 North America Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
44 North America Digital Therapeutics Market, By Country, 2021-2029 (USD Million)
45 U.S. Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
46 U.S. Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
47 U.S. Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
48 U.S. Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
49 Canada Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
50 Canada Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
51 Canada Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
52 CANADA Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
53 Mexico Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
54 Mexico Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
55 Mexico Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
56 mexico Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
57 Europe Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
58 Europe Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
59 Europe Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
60 europe Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
61 europe Digital Therapeutics Market, By Country, 2021-2029 (USD Million)
62 Germany Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
63 Germany Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
64 Germany Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
65 germany Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
66 UK Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
67 UK Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
68 UK Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
69 Uk Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
70 France Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
71 France Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
72 France Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
73 france Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
74 Italy Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
75 Italy Digital Therapeutics Market, By T Preservation Technique Type, 2021-2029 (USD Million)
76 Italy Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
77 italy Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
78 Spain Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
79 Spain Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
80 Spain Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
81 spain Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
82 Rest Of Europe Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
83 Rest Of Europe Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
84 Rest of Europe Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
85 REST OF EUROPE Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
86 Asia Pacific Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
87 Asia Pacific Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
88 Asia Pacific Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
89 asia Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
90 Asia Pacific Digital Therapeutics Market, By Country, 2021-2029 (USD Million)
91 China Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
92 China Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
93 China Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
94 china Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
95 India Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
96 India Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
97 India Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
98 india Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
99 Japan Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
100 Japan Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
101 Japan Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
102 japan Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
103 South Korea Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
104 South Korea Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
105 South Korea Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
106 south korea Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
107 Vietnam Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
108 Vietnam Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
109 Vietnam Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
110 Vietnam Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
111 Thailand Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
112 Thailand Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
113 Thailand Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
114 Thailand Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
115 Indonesia Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
116 Indonesia Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
117 Indonesia Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
118 Indonesia Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
119 Rest of Asia Pacific Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
120 Rest of Asia Pacific Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
121 Rest of Asia Pacific Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
122 Rest of Asia Pacific Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
123 Middle East and Africa Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
124 Middle East and Africa Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
125 Middle East and Africa Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
126 MIDDLE EAST AND AFRICA Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
127 Middle East and Africa Digital Therapeutics Market, By Country, 2021-2029 (USD Million)
128 Saudi Arabia Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
129 Saudi Arabia Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
130 Saudi Arabia Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
131 saudi arabia Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
132 UAE Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
133 UAE Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
134 UAE Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
135 uae Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
136 Qatar Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
137 Qatar Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
138 Qatar Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
139 Qatar Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
140 rest of Middle East and Africa Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
141 rest of Middle East and Africa Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
142 rest of Middle East and Africa Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
143 rest of Middle East and Africa Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
144 Central & South America Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
145 Central & South America Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
146 Central & South America Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
147 CENTRAL & SOUTH AMERICA Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
148 Central & South America Digital Therapeutics Market, By Country, 2021-2029 (USD Million)
149 Brazil Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
150 Brazil Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
151 Brazil Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
152 brazil Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
153 Argentina Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
154 Argentina Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
155 Argentina Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
156 Argentina Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
157 Rest of CENTRAL & SOUTH AMERICA Digital Therapeutics Market, By Offering, 2021-2029 (USD Million)
158 Rest of CENTRAL & SOUTH AMERICA Digital Therapeutics Market, By Revenue Model, 2021-2029 (USD Million)
159 Rest of CENTRAL & SOUTH AMERICA Digital Therapeutics Market, By Sales Channel, 2021-2029 (USD Million)
160 Rest of CENTRAL & SOUTH AMERICA Digital Therapeutics Market, By Application, 2021-2029 (USD Million)
161 Noom, Inc: Products & Services Offering
162 TELADOC HEALTH, INC.: Products & Services Offering
163 Omada Health, Inc.: Products & Services Offering
164 WellDoc, Inc: Products & Services Offering
165 Biofourmis: Products & Services Offering
166 BETTER THERAPEUTICS, INC: Products & Services Offering
167 Amalgm Rx: Products & Services Offering
168 CogniFit Inc: Products & Services Offering
169 HEADSPACE HEALTH: Products & Services Offering
170 Propeller Health: Products & Services Offering
171 VIRTA HEALTH CORP: Products & Services Offering
172 2Morrow, Inc.: Products & Services Offering
173 Realizedcare: Products & Services Offering
174 Canary Health: Products & Services Offering
175 Twill Inc.: Products & Services Offering
176 Click Therapeutics, Inc.: Products & Services Offering
177 AKILI, INC.: Products & Services Offering
178 Cognoa, Inc: Products & Services Offering
179 Wellthy Therapeutics Pvt. Ltd.: Products & Services Offering
180 Kaia Health: Products & Services Offering
181 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Digital Therapeutics Market Overview
2 Global Digital Therapeutics Market Value From 2021-2029 (USD Million)
3 Global Digital Therapeutics Market Share, By Offering (2023)
4 Global Digital Therapeutics Market Share, By Revenue Model (2023)
5 Global Digital Therapeutics Market Share, By Sales Channel (2023)
6 Global Digital Therapeutics Market Share, By Application (2023)
7 Global Digital Therapeutics Market, By Region (Asia Pacific Market)
8 Technological Trends In Global Digital Therapeutics Market
9 Four Quadrant Competitor Positioning Matrix
10 Impact Of Macro & Micro Indicators On The Market
11 Impact Of Key Drivers On The Global Digital Therapeutics Market
12 Impact Of Challenges On The Global Digital Therapeutics Market
13 Porter’s Five Forces Analysis
14 Global Digital Therapeutics Market: By Offering Scope Key Takeaways
15 Global Digital Therapeutics Market, By Offering Segment: Revenue Growth Analysis
16 Programs Market, By Region, 2021-2029 (USD Million)
17 Software/Platforms Market, By Region, 2021-2029 (USD Million)
18 Virtual Reality/Games Market, By Region, 2021-2029 (USD Million)
19 Global Digital Therapeutics Market: By Revenue Model Scope Key Takeaways
20 Global Digital Therapeutics Market, By Revenue Model Segment: Revenue Growth Analysis
21 Subscription Market, By Region, 2021-2029 (USD Million)
22 One time Purchase/Licensing Market, By Region, 2021-2029 (USD Million)
23 Outcome/Value based Market, By Region, 2021-2029 (USD Million)
24 Global Digital Therapeutics Market: By Sales Channel Scope Key Takeaways
25 Global Digital Therapeutics Market, By Sales Channel Segment: Revenue Growth Analysis
26 B2C Market, By Region, 2021-2029 (USD Million)
27 Patients Market, By Region, 2021-2029 (USD Million)
28 Caregivers Market, By Region, 2021-2029 (USD Million)
29 B2B Market, By Region, 2021-2029 (USD Million)
30 Providers Market, By Region, 2021-2029 (USD Million)
31 Payers Market, By Region, 2021-2029 (USD Million)
32 Employers Market, By Region, 2021-2029 (USD Million)
33 Pharmaceutical Companies Market, By Region, 2021-2029 (USD Million)
34 Others Market, By Region, 2021-2029 (USD Million)
35 Global Digital Therapeutics Market: By Application Scope Key Takeaways
36 Global Digital Therapeutics Market, By Application Segment: Revenue Growth Analysis
37 Preventive Applications Market, By Region, 2021-2029 (USD Million)
38 Prediabetes Market, By Region, 2021-2029 (USD Million)
39 Obesity Market, By Region, 2021-2029 (USD Million)
40 Nutrition Market, By Region, 2021-2029 (USD Million)
41 Lifestyle Management Market, By Region, 2021-2029 (USD Million)
42 Other Preventive Applications Market, By Region, 2021-2029 (USD Million)
43 Treatment/Care-related Applications Market, By Region, 2021-2029 (USD Million)
44 Diabetes Market, By Region, 2021-2029 (USD Million)
45 CNS Disorders Market, By Region, 2021-2029 (USD Million)
46 Mental Health Disorders Market, By Region, 2021-2029 (USD Million)
47 Chronic Respiratory Disorders Market, By Region, 2021-2029 (USD Million)
48 Musculoskeletal Disorders Market, By Region, 2021-2029 (USD Million)
49 Cardiovascular Diseases Market, By Region, 2021-2029 (USD Million)
50 Smoking Cessation Market, By Region, 2021-2029 (USD Million)
51 Medication Adherence Market, By Region, 2021-2029 (USD Million)
52 Gastrointestinal Disorders Market, By Region, 2021-2029 (USD Million)
53 Substance Use & Addiction Management Market, By Region, 2021-2029 (USD Million)
54 Rehabilitation & Patient Care Market, By Region, 2021-2029 (USD Million)
55 Other Treatment/Care-related Applications Market, By Region, 2021-2029 (USD Million)
56 Regional Segment: Revenue Growth Analysis
57 Global Digital Therapeutics Market: Regional Analysis
58 North America Digital Therapeutics Market Overview
59 North America Digital Therapeutics Market, By Offering
60 North America Digital Therapeutics Market, By Revenue Model
61 North America Digital Therapeutics Market, By Sales Channel
62 North America Digital Therapeutics Market, By Application
63 North America Digital Therapeutics Market, By Country
64 U.S. Digital Therapeutics Market, By Offering
65 U.S. Digital Therapeutics Market, By Revenue Model
66 U.S. Digital Therapeutics Market, By Sales Channel
67 U.S. Digital Therapeutics Market, By Application
68 Canada Digital Therapeutics Market, By Offering
69 Canada Digital Therapeutics Market, By Revenue Model
70 Canada Digital Therapeutics Market, By Sales Channel
71 Canada Digital Therapeutics Market, By Application
72 Mexico Digital Therapeutics Market, By Offering
73 Mexico Digital Therapeutics Market, By Revenue Model
74 Mexico Digital Therapeutics Market, By Sales Channel
75 Mexico Digital Therapeutics Market, By Application
76 Four Quadrant Positioning Matrix
77 Company Market Share Analysis
78 Noom, Inc: Company Snapshot
79 Noom, Inc: SWOT Analysis
80 Noom, Inc: Geographic Presence
81 TELADOC HEALTH, INC.: Company Snapshot
82 TELADOC HEALTH, INC.: SWOT Analysis
83 TELADOC HEALTH, INC.: Geographic Presence
84 Omada Health, Inc.: Company Snapshot
85 Omada Health, Inc.: SWOT Analysis
86 Omada Health, Inc.: Geographic Presence
87 WellDoc, Inc: Company Snapshot
88 WellDoc, Inc: Swot Analysis
89 WellDoc, Inc: Geographic Presence
90 Biofourmis: Company Snapshot
91 Biofourmis: SWOT Analysis
92 Biofourmis: Geographic Presence
93 BETTER THERAPEUTICS, INC: Company Snapshot
94 BETTER THERAPEUTICS, INC: SWOT Analysis
95 BETTER THERAPEUTICS, INC: Geographic Presence
96 Amalgm Rx: Company Snapshot
97 Amalgm Rx: SWOT Analysis
98 Amalgm Rx: Geographic Presence
99 CogniFit Inc: Company Snapshot
100 CogniFit Inc: SWOT Analysis
101 CogniFit Inc: Geographic Presence
102 HEADSPACE HEALTH.: Company Snapshot
103 HEADSPACE HEALTH.: SWOT Analysis
104 HEADSPACE HEALTH.: Geographic Presence
105 Propeller Health: Company Snapshot
106 Propeller Health: SWOT Analysis
107 Propeller Health: Geographic Presence
108 VIRTA HEALTH CORP: Company Snapshot
109 VIRTA HEALTH CORP: SWOT Analysis
110 VIRTA HEALTH CORP: Geographic Presence
111 2Morrow, Inc.: Company Snapshot
112 2Morrow, Inc.: SWOT Analysis
113 2Morrow, Inc.: Geographic Presence
114 Realizedcare: Company Snapshot
115 Realizedcare: SWOT Analysis
116 Realizedcare: Geographic Presence
117 Canary Health: Company Snapshot
118 Canary Health: SWOT Analysis
119 Canary Health: Geographic Presence
120 Twill Inc.: Company Snapshot
121 Twill Inc.: SWOT Analysis
122 Twill Inc.: Geographic Presence
123 Click Therapeutics, Inc.: Company Snapshot
124 Click Therapeutics, Inc.: SWOT Analysis
125 Click Therapeutics, Inc.: Geographic Presence
126 AKILI, INC.: Company Snapshot
127 AKILI, INC.: SWOT Analysis
128 AKILI, INC.: Geographic Presence
129 HCLTech: Company Snapshot
130 HCLTech: SWOT Analysis
131 HCLTech: Geographic Presence
132 Wellthy Therapeutics Pvt. Ltd.: Company Snapshot
133 Wellthy Therapeutics Pvt. Ltd.: SWOT Analysis
134 Wellthy Therapeutics Pvt. Ltd.: Geographic Presence
135 Kaia Health: Company Snapshot
136 Kaia Health: SWOT Analysis
137 Kaia Health: Geographic Presence
138 Other Companies: Company Snapshot
139 Other Companies: SWOT Analysis
140 Other Companies: Geographic Presence
The Global Digital Therapeutics Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Digital Therapeutics Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
